Positive drugs list for Germany, despite criticisms
Gespeichert in:
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1995 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: PharmacoEconomics & outcomes news - [Cham] : Springer Nature Switzerland, 1996, 36(1995), 1 vom: Sept., Seite 15-15 |
|---|---|
| Übergeordnetes Werk: |
volume:36 ; year:1995 ; number:1 ; month:09 ; pages:15-15 |
| Links: |
|---|
| DOI / URN: |
10.1007/BF03309782 |
|---|
| Katalog-ID: |
SPR033366187 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR033366187 | ||
| 003 | DE-627 | ||
| 005 | 20230519073937.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s1995 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/BF03309782 |2 doi | |
| 035 | |a (DE-627)SPR033366187 | ||
| 035 | |a (SPR)BF03309782-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 070 |a 610 |q ASE |
| 084 | |a 44.40 |2 bkl | ||
| 245 | 1 | 0 | |a Positive drugs list for Germany, despite criticisms |
| 264 | 1 | |c 1995 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 650 | 4 | |a Asthma |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Drug Category |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a General Practitioner Consultation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Health Service Cost |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a National Health Service Cost |7 (dpeaa)DE-He213 | |
| 773 | 0 | 8 | |i Enthalten in |t PharmacoEconomics & outcomes news |d [Cham] : Springer Nature Switzerland, 1996 |g 36(1995), 1 vom: Sept., Seite 15-15 |w (DE-627)393747956 |w (DE-600)2159696-7 |x 1179-2043 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:1995 |g number:1 |g month:09 |g pages:15-15 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/BF03309782 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2190 | ||
| 936 | b | k | |a 44.40 |q ASE |
| 951 | |a AR | ||
| 952 | |d 36 |j 1995 |e 1 |c 09 |h 15-15 | ||
| matchkey_str |
article:11792043:1995----::oiierglsfremndsi |
|---|---|
| hierarchy_sort_str |
1995 |
| bklnumber |
44.40 |
| publishDate |
1995 |
| allfields |
10.1007/BF03309782 doi (DE-627)SPR033366187 (SPR)BF03309782-e DE-627 ger DE-627 rakwb eng 070 610 ASE 44.40 bkl Positive drugs list for Germany, despite criticisms 1995 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Asthma (dpeaa)DE-He213 Drug Category (dpeaa)DE-He213 General Practitioner Consultation (dpeaa)DE-He213 Health Service Cost (dpeaa)DE-He213 National Health Service Cost (dpeaa)DE-He213 Enthalten in PharmacoEconomics & outcomes news [Cham] : Springer Nature Switzerland, 1996 36(1995), 1 vom: Sept., Seite 15-15 (DE-627)393747956 (DE-600)2159696-7 1179-2043 nnns volume:36 year:1995 number:1 month:09 pages:15-15 https://dx.doi.org/10.1007/BF03309782 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 36 1995 1 09 15-15 |
| spelling |
10.1007/BF03309782 doi (DE-627)SPR033366187 (SPR)BF03309782-e DE-627 ger DE-627 rakwb eng 070 610 ASE 44.40 bkl Positive drugs list for Germany, despite criticisms 1995 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Asthma (dpeaa)DE-He213 Drug Category (dpeaa)DE-He213 General Practitioner Consultation (dpeaa)DE-He213 Health Service Cost (dpeaa)DE-He213 National Health Service Cost (dpeaa)DE-He213 Enthalten in PharmacoEconomics & outcomes news [Cham] : Springer Nature Switzerland, 1996 36(1995), 1 vom: Sept., Seite 15-15 (DE-627)393747956 (DE-600)2159696-7 1179-2043 nnns volume:36 year:1995 number:1 month:09 pages:15-15 https://dx.doi.org/10.1007/BF03309782 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 36 1995 1 09 15-15 |
| allfields_unstemmed |
10.1007/BF03309782 doi (DE-627)SPR033366187 (SPR)BF03309782-e DE-627 ger DE-627 rakwb eng 070 610 ASE 44.40 bkl Positive drugs list for Germany, despite criticisms 1995 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Asthma (dpeaa)DE-He213 Drug Category (dpeaa)DE-He213 General Practitioner Consultation (dpeaa)DE-He213 Health Service Cost (dpeaa)DE-He213 National Health Service Cost (dpeaa)DE-He213 Enthalten in PharmacoEconomics & outcomes news [Cham] : Springer Nature Switzerland, 1996 36(1995), 1 vom: Sept., Seite 15-15 (DE-627)393747956 (DE-600)2159696-7 1179-2043 nnns volume:36 year:1995 number:1 month:09 pages:15-15 https://dx.doi.org/10.1007/BF03309782 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 36 1995 1 09 15-15 |
| allfieldsGer |
10.1007/BF03309782 doi (DE-627)SPR033366187 (SPR)BF03309782-e DE-627 ger DE-627 rakwb eng 070 610 ASE 44.40 bkl Positive drugs list for Germany, despite criticisms 1995 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Asthma (dpeaa)DE-He213 Drug Category (dpeaa)DE-He213 General Practitioner Consultation (dpeaa)DE-He213 Health Service Cost (dpeaa)DE-He213 National Health Service Cost (dpeaa)DE-He213 Enthalten in PharmacoEconomics & outcomes news [Cham] : Springer Nature Switzerland, 1996 36(1995), 1 vom: Sept., Seite 15-15 (DE-627)393747956 (DE-600)2159696-7 1179-2043 nnns volume:36 year:1995 number:1 month:09 pages:15-15 https://dx.doi.org/10.1007/BF03309782 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 36 1995 1 09 15-15 |
| allfieldsSound |
10.1007/BF03309782 doi (DE-627)SPR033366187 (SPR)BF03309782-e DE-627 ger DE-627 rakwb eng 070 610 ASE 44.40 bkl Positive drugs list for Germany, despite criticisms 1995 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Asthma (dpeaa)DE-He213 Drug Category (dpeaa)DE-He213 General Practitioner Consultation (dpeaa)DE-He213 Health Service Cost (dpeaa)DE-He213 National Health Service Cost (dpeaa)DE-He213 Enthalten in PharmacoEconomics & outcomes news [Cham] : Springer Nature Switzerland, 1996 36(1995), 1 vom: Sept., Seite 15-15 (DE-627)393747956 (DE-600)2159696-7 1179-2043 nnns volume:36 year:1995 number:1 month:09 pages:15-15 https://dx.doi.org/10.1007/BF03309782 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 36 1995 1 09 15-15 |
| language |
English |
| source |
Enthalten in PharmacoEconomics & outcomes news 36(1995), 1 vom: Sept., Seite 15-15 volume:36 year:1995 number:1 month:09 pages:15-15 |
| sourceStr |
Enthalten in PharmacoEconomics & outcomes news 36(1995), 1 vom: Sept., Seite 15-15 volume:36 year:1995 number:1 month:09 pages:15-15 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Asthma Drug Category General Practitioner Consultation Health Service Cost National Health Service Cost |
| dewey-raw |
070 |
| isfreeaccess_bool |
false |
| container_title |
PharmacoEconomics & outcomes news |
| publishDateDaySort_date |
1995-09-01T00:00:00Z |
| hierarchy_top_id |
393747956 |
| dewey-sort |
270 |
| id |
SPR033366187 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR033366187</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519073937.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1995 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03309782</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR033366187</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03309782-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">070</subfield><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Positive drugs list for Germany, despite criticisms</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1995</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Asthma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Category</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">General Practitioner Consultation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Service Cost</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">National Health Service Cost</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">PharmacoEconomics & outcomes news</subfield><subfield code="d">[Cham] : Springer Nature Switzerland, 1996</subfield><subfield code="g">36(1995), 1 vom: Sept., Seite 15-15</subfield><subfield code="w">(DE-627)393747956</subfield><subfield code="w">(DE-600)2159696-7</subfield><subfield code="x">1179-2043</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:36</subfield><subfield code="g">year:1995</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:15-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03309782</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">36</subfield><subfield code="j">1995</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">15-15</subfield></datafield></record></collection>
|
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)393747956 |
| format |
electronic Article |
| dewey-ones |
070 - News media, journalism & publishing 610 - Medicine & health |
| delete_txt_mv |
keep |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1179-2043 |
| topic_title |
070 610 ASE 44.40 bkl Positive drugs list for Germany, despite criticisms Asthma (dpeaa)DE-He213 Drug Category (dpeaa)DE-He213 General Practitioner Consultation (dpeaa)DE-He213 Health Service Cost (dpeaa)DE-He213 National Health Service Cost (dpeaa)DE-He213 |
| topic |
ddc 070 bkl 44.40 misc Asthma misc Drug Category misc General Practitioner Consultation misc Health Service Cost misc National Health Service Cost |
| spellingShingle |
ddc 070 bkl 44.40 misc Asthma misc Drug Category misc General Practitioner Consultation misc Health Service Cost misc National Health Service Cost Positive drugs list for Germany, despite criticisms |
| topic_unstemmed |
ddc 070 bkl 44.40 misc Asthma misc Drug Category misc General Practitioner Consultation misc Health Service Cost misc National Health Service Cost |
| topic_browse |
ddc 070 bkl 44.40 misc Asthma misc Drug Category misc General Practitioner Consultation misc Health Service Cost misc National Health Service Cost |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
PharmacoEconomics & outcomes news |
| hierarchy_parent_id |
393747956 |
| dewey-tens |
070 - News media, journalism & publishing 610 - Medicine & health |
| hierarchy_top_title |
PharmacoEconomics & outcomes news |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)393747956 (DE-600)2159696-7 |
| title |
Positive drugs list for Germany, despite criticisms |
| ctrlnum |
(DE-627)SPR033366187 (SPR)BF03309782-e |
| title_full |
Positive drugs list for Germany, despite criticisms |
| journal |
PharmacoEconomics & outcomes news |
| journalStr |
PharmacoEconomics & outcomes news |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
000 - Computer science, information & general works 600 - Technology |
| recordtype |
marc |
| publishDateSort |
1995 |
| contenttype_str_mv |
txt |
| container_start_page |
15 |
| container_volume |
36 |
| class |
070 610 ASE 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| doi_str_mv |
10.1007/BF03309782 |
| dewey-full |
070 610 |
| title_sort |
positive drugs list for germany, despite criticisms |
| title_auth |
Positive drugs list for Germany, despite criticisms |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 |
| container_issue |
1 |
| title_short |
Positive drugs list for Germany, despite criticisms |
| url |
https://dx.doi.org/10.1007/BF03309782 |
| remote_bool |
true |
| ppnlink |
393747956 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/BF03309782 |
| up_date |
2024-07-03T18:11:14.934Z |
| _version_ |
1803582465574436864 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR033366187</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519073937.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1995 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03309782</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR033366187</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03309782-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">070</subfield><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Positive drugs list for Germany, despite criticisms</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1995</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Asthma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Category</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">General Practitioner Consultation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Service Cost</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">National Health Service Cost</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">PharmacoEconomics & outcomes news</subfield><subfield code="d">[Cham] : Springer Nature Switzerland, 1996</subfield><subfield code="g">36(1995), 1 vom: Sept., Seite 15-15</subfield><subfield code="w">(DE-627)393747956</subfield><subfield code="w">(DE-600)2159696-7</subfield><subfield code="x">1179-2043</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:36</subfield><subfield code="g">year:1995</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:15-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03309782</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">36</subfield><subfield code="j">1995</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">15-15</subfield></datafield></record></collection>
|
| score |
7.3998833 |